Equifax INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Capital International Investors reports a 3.2% stake in Equifax Inc. as of March 31, 2026, holding 3,820,844 shares.
NYSE
Vanguard Capital Management has reported a 7.47% beneficial ownership stake in Equifax Inc. as of March 31, 2026.
NYSE
The Vanguard Group has reported zero beneficial ownership in Equifax Inc. common stock following an internal realignment that disaggregated its reporting.
NYSE
The Vanguard Group has filed an amended Schedule 13G, disclosing a beneficial ownership of 12.34% in Equifax Inc. common stock as of September 30, 2025.
NYSE
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in Equifax Inc.
NYSE
Capital International Investors has disclosed an 8.6% beneficial ownership stake in Equifax Inc., holding over 10.6 million shares as of June 30, 2025.
NYSE
T. Rowe Price Associates, Inc. has filed a Schedule 13G, revealing a passive beneficial ownership of 5.6% of Equifax Inc.'s common stock as of March 31, 2025.
NYSE
Capital International Investors has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Equifax Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 6.9% passive beneficial ownership stake in Equifax Inc. as of December 31, 2024.